Hussman Strategic Advisors’s ResMed RMD Stock Holding History

Hussman Strategic Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,300	Closed	-$1.44M	–	309
2024 Q4	$1.44M	Buy	+6,300	New	+$1.52M	0.43%	100
2017 Q1	–	Sell	-2,300	Closed	-$143K	–	226
2016 Q4	$143K	Hold	2,300	–	–	0.03%	123
2016 Q3	$149K	Hold	2,300	–	–	0.02%	115
2016 Q2	$145K	Hold	2,300	–	–	0.02%	119
2016 Q1	$133K	Sell	2,300 -47,700	-95%	-$2.7M	0.02%	150
2015 Q4	$2.68M	Hold	50,000	–	–	0.38%	100
2015 Q3	$2.55M	Sell	50,000 -25,000	-33%	-$1.35M	0.32%	112
2015 Q2	$4.23M	Buy	75,000 +71,500	+2,043%	+$4.51M	0.49%	84
2015 Q1	$251K	Hold	3,500	–	–	0.03%	138
2014 Q4	$196K	Buy	+3,500	New	+$183K	0.02%	155
2014 Q1	–	Sell	-235,000	Closed	-$11.1M	–	213
2013 Q4	$11.1M	Sell	235,000 -80,000	-25%	-$4.05M	0.79%	61
2013 Q3	$16.6M	Sell	315,000 -35,000	-10%	-$1.7M	0.91%	52
2013 Q2	$15.8M	Buy	+350,000	New	+$16.6M	0.72%	66

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Hussman Strategic Advisors's RMD Position: Q1 2025 in Review

Hussman Strategic Advisors sold out of ResMed (RMD) in Q1 2025, closing a stake of 6,300 shares — an estimated $1.44M sold.

Hussman Strategic Advisors first reported a position in RMD in Q2 2013 and held it in 13 quarters. The position peaked at $16.6M in Q3 2013. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Hussman Strategic Advisors reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Hussman Strategic Advisors sold 6,300 ResMed shares in Q1 2025, an estimated $1.44M.
Hussman Strategic Advisors first reported a position in ResMed in Q2 2013 and held it in 13 quarters.
Hussman Strategic Advisors's ResMed position peaked at $16.6M in Q3 2013.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Hussman Strategic Advisors's 13F filing for Q1 2025, filed 5 May 2025.